NEW ENGLAND ASSET MANAGEMENT INC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW ENGLAND ASSET MANAGEMENT INC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2021$10,000
-99.0%
563
-99.0%
0.00%
-100.0%
Q4 2020$1,009,000
+2.0%
55,4260.0%0.02%
-16.7%
Q3 2020$989,000
+0.2%
55,426
+0.7%
0.02%0.0%
Q2 2020$987,000
+18.2%
55,0260.0%0.02%
+20.0%
Q1 2020$835,000
-21.1%
55,026
+2.6%
0.02%
+17.6%
Q4 2019$1,058,000
+14.8%
53,6260.0%0.02%0.0%
Q3 2019$922,000
-2.8%
53,6260.0%0.02%
-10.5%
Q2 2019$949,000
+19.7%
53,626
+37.7%
0.02%
+26.7%
Q1 2019$793,00038,9320.02%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2023
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders